Experience

• • A global pharmaceutical company in an internal investigation into Al-related IP theft and data-loss prevention.
  • A global pharmaceutical company on Al governance and regulatory compliance issues across a decentralized collection of business units with distinct operational and regulatory risk profiles.
  • The Securities Industry and Financial Markets Association (SIFMA) and the Global Financial Markets Association (GFMA), leading trade associations that represent the financial services industry, in preparing comment letters regarding regulatory developments in cybersecurity, operational resilience and artificial intelligence.
  • A major entertainment company and a Fortune 500 company in negotiations of agreements with Microsoft, OpenAI, AWS and/or Google related to generative AI services.
  • A major U.S. medical data provider on IP protection and Al licensing issues.
  • A multinational publishing company on licensing of non-fiction works for AI training and development.
  • Multiple financial services companies in regulatory examinations and enforcement matters related to use and marketing of Al and machine learning.
  • Several large private equity firms on implementing AI policies, creating AI governance committees, responding to regulatory inquires on AI use, AI vendor risk management, AI training and risk management for portfolio companies.
  • Several large insurance companies on AI governance, regulatory compliance (including drafting Colorado AI certifications), risk assessments, AI policies, AI vendor management, bias assessments and training, AI incident playbooks, AI tabletop exercises, and board briefings on AI risk and oversight.